Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients


CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.transci.2018.09.013
  • Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.752-755
  • Anahtar Kelimeler: Acute myeloid leukemia, Allogeneic stem cell transplantation, High-Dose cytarabine, ACUTE MYELOGENOUS LEUKEMIA, MAINTENANCE CHEMOTHERAPY, REMISSION, THERAPY, ADULTS, DAUNORUBICIN, SURVIVAL
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background and Aim: This is a retrospective study aiming to investigate the effect of the number of high dose cytarabine-based chemotherapy (HiDAC) courses in patients with acute myeloid leukemia before allogenic stem cell transplantation (ASCT).